Advertisement
Research Article

Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool

  • Rachel M. Ostroff equal contributor mail,

    equal contributor Contributed equally to this work with: Rachel M. Ostroff, Michael R. Mehan

    rostroff@somalogic.com

    Affiliation: Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

    X
  • Michael R. Mehan equal contributor,

    equal contributor Contributed equally to this work with: Rachel M. Ostroff, Michael R. Mehan

    Affiliation: Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

    X
  • Alex Stewart,

    Affiliation: Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

    X
  • Deborah Ayers,

    Affiliation: Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

    X
  • Edward N. Brody,

    Affiliation: Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

    X
  • Stephen A. Williams,

    Affiliation: Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

    X
  • Stephen Levin,

    Affiliation: Center for Occupational and Environmental Medicine, Mt. Sinai Medical Center, New York, New York, United States of America

    X
  • Brad Black,

    Affiliation: Center for Asbestos Related Diseases, Libby, Montana, United States of America

    X
  • Michael Harbut,

    Affiliation: Environmental Cancer Program, Karmanos Cancer Center, Detroit, Michigan, United States of America

    X
  • Michele Carbone,

    Affiliation: Department of Pathology, Cancer Research Center of Hawaii, Honolulu, Hawaii, United States of America

    X
  • Chandra Goparaju,

    Affiliation: Department of Cardiothoracic Surgery, New York University Langone Medical Center and Cancer Center, New York, New York, United States of America

    X
  • Harvey I. Pass

    Affiliation: Department of Cardiothoracic Surgery, New York University Langone Medical Center and Cancer Center, New York, New York, United States of America

    X
  • Published: October 03, 2012
  • DOI: 10.1371/journal.pone.0046091

Reader Comments (1)

Post a new comment on this article

Media Coverage of This Article

Posted by PLoS_ONE_Group on 05 Oct 2012 at 20:05 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: EurekAlert
Title: “Novel blood-based protein signature determined for rare, aggressive lung cancer”
http://www.eurekalert.org...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff

RE: Media Coverage of This Article

PLoS_ONE_Group replied to PLoS_ONE_Group on 12 Oct 2012 at 23:00 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: GenomeWeb ProteoMonitor
Title: “Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma | ProteoMonitor | Proteomics | GenomeWeb”
http://www.genomeweb.com/...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff

RE: RE: Media Coverage of This Article

PLoS_ONE_Group replied to PLoS_ONE_Group on 19 Oct 2012 at 21:05 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: HemOncToday
Title: “Biomarkers detected mesothelioma after asbestos exposure | Hematology Oncology”
http://www.healio.com/hem...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff